255 related articles for article (PubMed ID: 25989455)
1. Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.
Paik JJ; Wigley FM; Lloyd TE; Corse AM; Casciola-Rosen L; Shah AA; Boin F; Hummers LK; Mammen AL
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1416-25. PubMed ID: 25989455
[TBL] [Abstract][Full Text] [Related]
2. Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology.
Bhansing KJ; Lammens M; Knaapen HK; van Riel PL; van Engelen BG; Vonk MC
Arthritis Res Ther; 2014 May; 16(3):R111. PubMed ID: 24886750
[TBL] [Abstract][Full Text] [Related]
3. Histopathological features of systemic sclerosis-associated myopathy: A scoping review.
Lefebvre F; Giannini M; Ellezam B; Leclair V; Troyanov Y; Hoa S; Bourré-Tessier J; Satoh M; Fritzler MJ; Senécal JL; Hudson M; Meyer A; Landon-Cardinal O
Autoimmun Rev; 2021 Jul; 20(7):102851. PubMed ID: 33971337
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis-associated myopathy.
Ranque B; Authier FJ; Berezne A; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Jun; 1108():268-82. PubMed ID: 17899625
[TBL] [Abstract][Full Text] [Related]
5. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
6. Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality.
Paik JJ; Wigley FM; Shah AA; Corse AM; Casciola-Rosen L; Hummers LK; Mammen AL
Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1764-1770. PubMed ID: 28544788
[TBL] [Abstract][Full Text] [Related]
7. Serum muscle enzymes, muscle pathology and clinical muscle weakness: correlation in Thai patients with polymyositis/dermatomyositis.
Louthrenoo W; Weerayutwattana N; Lertprasertsuke N; Sukitawut W
J Med Assoc Thai; 2002 Jan; 85(1):26-32. PubMed ID: 12075717
[TBL] [Abstract][Full Text] [Related]
8. Polymyositis: an overdiagnosed entity.
van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
[TBL] [Abstract][Full Text] [Related]
9. The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.
Pinal-Fernandez I; Casciola-Rosen LA; Christopher-Stine L; Corse AM; Mammen AL
J Rheumatol; 2015 Aug; 42(8):1448-54. PubMed ID: 26443871
[TBL] [Abstract][Full Text] [Related]
10. Inclusion body myositis: clinical and pathological boundaries.
Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
[TBL] [Abstract][Full Text] [Related]
11. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index.
Rider LG; Lachenbruch PA; Monroe JB; Ravelli A; Cabalar I; Feldman BM; Villalba ML; Myones BL; Pachman LM; Rennebohm RM; Reed AM; Miller FW;
Arthritis Rheum; 2009 Nov; 60(11):3425-35. PubMed ID: 19877055
[TBL] [Abstract][Full Text] [Related]
12. Immune Mediated Necrotizing Myopathy: a Cause of Isolated Myopathy of Neck Extensor Muscle.
Sehgal R; Medina-Flores R; Yachoui R; Kenney CV
Clin Med Res; 2016 Dec; 14(3-4):145-150. PubMed ID: 27573534
[TBL] [Abstract][Full Text] [Related]
13. Muscle involvement in the scleroderma syndromes.
Ringel RA; Brick JE; Brick JF; Gutmann L; Riggs JE
Arch Intern Med; 1990 Dec; 150(12):2550-2. PubMed ID: 2244771
[TBL] [Abstract][Full Text] [Related]
14. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
Basharat P; Christopher-Stine L
Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
[TBL] [Abstract][Full Text] [Related]
15. Muscle disease in scleroderma.
Paik JJ
Curr Opin Rheumatol; 2018 Nov; 30(6):576-580. PubMed ID: 30148800
[TBL] [Abstract][Full Text] [Related]
16. Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma.
Paik JJ; Wigley FM; Mejia AF; Hummers LK
Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1695-1703. PubMed ID: 26881982
[TBL] [Abstract][Full Text] [Related]
17. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.
Clements PJ; Furst DE; Campion DS; Bohan A; Harris R; Levy J; Paulus HE
Arthritis Rheum; 1978; 21(1):62-71. PubMed ID: 623695
[TBL] [Abstract][Full Text] [Related]
18. [Role of magnetic resonance imaging in the diagnosis of juvenile dermato-myositis and polymyositis in Chinese children].
Lai JM; Wu FQ; Zhou ZX; Yuan XY; Su GX; Li SN; Yan YC; Zhu J; Kang M
Zhonghua Er Ke Za Zhi; 2016 Oct; 54(10):767-772. PubMed ID: 27784480
[No Abstract] [Full Text] [Related]
19. Muscle abnormalities in scleroderma.
Olsen NJ; King LE; Park JH
Rheum Dis Clin North Am; 1996 Nov; 22(4):783-96. PubMed ID: 8923596
[TBL] [Abstract][Full Text] [Related]
20. Myopathy in scleroderma and in other connective tissue diseases.
Paik JJ
Curr Opin Rheumatol; 2016 Nov; 28(6):631-5. PubMed ID: 27548651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
